Literature DB >> 34191050

Persistent Abnormal Immunocytes Induced Systemic Bone Loss in Locally Irradiated Rats.

Wei Hong1,2, Lichen Tang3, Rui Ge4, Weiping Li4, Xiaoyong Shen5, Lixia Hong4, Xiaoya Xu6.   

Abstract

Chronic and systemic bone complications frequently occur in patients who undergo radiotherapy; however, the pathological mechanisms underlying these complications remain unclear. This study aimed to observe persistent and systemic changes in locally irradiated rats and to determine the systemic pathological changes that persistently affect bone metabolism. We examined the inflammatory and oxidative stress responses that occurred after local irradiation using enzyme immunoassays and biochemical analyses. Lymphocytes obtained from the blood, spleen, thymus, and bone marrow were evaluated using flow cytometry. The proliferation and apoptosis characteristics of co-cultured bone marrow-derived mesenchymal stem cells (BMSCs) were detected by MTT assay and PI/Annexin V-FITC staining, respectively, and the differentiation of BMSCs was measured according to alkaline phosphatase (ALP) staining, alizarin red staining, and Oil Red O staining and by evaluating the mRNA expression of ALP, osteocalcin (OCN), osteopontin (OPN), collagen I, Runx2, and PPARγ. Our results revealed that no significant or continuous differences were present in the inflammatory response or the oxidative stress response throughout the body after local irradiation. B lymphocyte levels increased continuously in the blood, spleen, and bone marrow after local irradiation. T lymphocyte levels were decreased at 2 weeks after local irradiation, and CD8+T lymphocyte levels were increased in the blood, thymus, and bone marrow at 12 weeks after local irradiation. The ratio of CD4+/CD8+T lymphocytes began to decrease during the early phase after local irradiation and became significantly decreased at 12 weeks after local irradiation. Normal BMSCs co-cultured with lymphocytes derived from irradiated rats exhibited decreased proliferation and increased apoptosis, and the ALP staining intensity, alizarin red staining intensity, and mRNA expression of related genes were all also decreased. Oil Red O staining intensity and mRNA expression of PPARγ were both increased. Lymphocyte levels contribute to chronic and systemic bone complications after radiotherapy by inhibiting the proliferation and osteoblastogenesis of BMSCs.

Entities:  

Keywords:  B lymphocyte; Bone loss; Irradiation; T lymphocyte

Year:  2021        PMID: 34191050     DOI: 10.1007/s00223-021-00883-8

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  29 in total

1.  Bone health in women with breast cancer.

Authors:  S K Ramchand; Y M Cheung; M Grossmann
Journal:  Climacteric       Date:  2019-03-21       Impact factor: 3.005

2.  Pathological fracture after radiotherapy: systematic review of literature.

Authors:  Cláudio Beling Gonçalves Soares; Ivana Duval de Araújo; Bruno Jannotti Pádua; José Carlos Souza Vilela; Rodrigo Henriques Reis Souza; Luiz Eduardo Moreira Teixeira
Journal:  Rev Assoc Med Bras (1992)       Date:  2019-07-22       Impact factor: 1.209

3.  Rapid loss of bone mass and strength in mice after abdominal irradiation.

Authors:  Dan Jia; Dana Gaddy; Larry J Suva; Peter M Corry
Journal:  Radiat Res       Date:  2011-08-22       Impact factor: 2.841

4.  Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative.

Authors:  Z Chen; M Maricic; A K Aragaki; C Mouton; L Arendell; A M Lopez; T Bassford; R T Chlebowski
Journal:  Osteoporos Int       Date:  2008-09-03       Impact factor: 4.507

Review 5.  Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications.

Authors:  S D'Oronzo; S Stucci; M Tucci; F Silvestris
Journal:  Cancer Treat Rev       Date:  2015-09-15       Impact factor: 12.111

6.  Single-Limb Irradiation Induces Local and Systemic Bone Loss in a Murine Model.

Authors:  Laura E Wright; Jeroen T Buijs; Hun-Soo Kim; Laura E Coats; Anne M Scheidler; Sutha K John; Yun She; Sreemala Murthy; Ning Ma; Helen J Chin-Sinex; Teresita M Bellido; Ted A Bateman; Marc S Mendonca; Khalid S Mohammad; Theresa A Guise
Journal:  J Bone Miner Res       Date:  2015-06-08       Impact factor: 6.741

Review 7.  Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.

Authors:  Stefan Heinrich; Hauke Lang
Journal:  Int J Mol Sci       Date:  2017-07-26       Impact factor: 5.923

8.  Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study.

Authors:  Yu-Mei Kang; Tze-Fan Chao; Ti-Hao Wang; Yu-Wen Hu
Journal:  Cancer Med       Date:  2019-05-18       Impact factor: 4.452

9.  Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions.

Authors:  Unni S Pillai; Smita Kayal; Sunu Cyriac; Yadav Nisha; Kadambari Dharanipragada; Sadish Kumar Kamalanathan; Dhanapathi Halanaik; Navin Kumar; Ponraj Madasamy; Dhanraju Krishnappa Muniswamy; Biswajit Dubashi
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

Review 10.  The Emerging Role of GC-MSCs in the Gastric Cancer Microenvironment: From Tumor to Tumor Immunity.

Authors:  Zhaoji Pan; Yiqing Tian; Guoping Niu; Chengsong Cao
Journal:  Stem Cells Int       Date:  2019-12-02       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.